Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Nursing the World to Health: Celebrating Fresenius Kidney Care Nurses' Contribution in Asia Pacific on International Nurses Day

share with twitter share with LinkedIn share with facebook
05/12/2020 | 12:28am EDT

Today, on International Nurses Day, Fresenius Medical Care, the world’s leading provider of dialysis products and services, is celebrating the extraordinary contribution that its nurses make to the organization and wider community – every day, and particularly in the face of our current global health challenge.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200511005990/en/

Fresenius Kidney Care nurses volunteered to care for dialysis patients who contracted COVID-19 in Wuhan, China, where the outbreak first took place. (Photo: Business Wire)

Fresenius Kidney Care nurses volunteered to care for dialysis patients who contracted COVID-19 in Wuhan, China, where the outbreak first took place. (Photo: Business Wire)

Throughout the world, International Nurses Day is celebrated on 12 May, the birthday of Florence Nightingale: founder of modern nursing and infection control. This year, the day is particularly noteworthy, as it marks the 200-year anniversary of Nightingale’s birth with 2020 declared as the World Health Organization’s (WHO) International Year of the Nurse and Midwife. It is also very fitting that 2020 will be remembered as the year that the COVID-19 pandemic shook healthcare systems to their core and where, more than ever before, nurses rose to the challenge of caring for patients on the frontline.

‘Stories of Strength’ by Fresenius Kidney Care nurses

At Fresenius Kidney Care, the dialysis care services division of Fresenius Medical Care, nurses have demonstrated the critical role of nurses during the pandemic. Some of them volunteered to care for dialysis patients who contracted COVID-19 in Wuhan, China, where the outbreak first took place. Qun Xiao, who was one of the first nurses to treat infected dialysis patients, recalls that she initially felt anxious about her role, but those feelings disappeared when she saw her patients, many of whom had been not received their life-sustaining dialysis treatment for days. “Their faces simply lit up when they saw us. We were their hope,” she recalls.

Liangju Jiao, who has been a dialysis nurse for 20 years, says that her role was like nothing she had ever done before, with exhausting shifts spent in full personal protective equipment (PPE). “At first, I was worried about getting infected. But when I saw patients getting help and being cared for, I felt that it was all worth it. Some even called us life-saving angels,” Liangju reflected.

Supporting Fresenius Kidney Care nurses during the global pandemic

Practical support on the ground has been vital for nurses during the global pandemic. Fresenius Medical Care employees have been quick to provide infection prevention and control guidance, and have often gone to remarkable lengths to secure PPE for nurses. The company’s human resources departments across Asia Pacific are working together to provide access to counselling services for ongoing support. Office-based employees have delivered ‘Share that you care’ video messages to nurses, as a personal way of acknowledging and thanking nurses for all that they do.

‘Hearts for Hearts’ campaign

Throughout the year, and specifically on International Nurses Day, Fresenius Kidney Care hosts special events to recognize and engage with nurses. This year, the organization has created a nurse engagement campaign ‘Hearts for Hearts’. The campaign’s name stems from nurses being the heart of Fresenius Kidney Care and having big hearts for their patients – who show their love and respect for nurses in return. Additionally, everyone in the organization has a heart for our nurses.

At the core of the Hearts for Hearts campaign is a dedicated online hub for the company’s nurses, providing a place to celebrate the joys and acknowledge the challenges of being a dialysis nurse in the 21st Century. The site includes information, resources and practical tools to help nurses navigate the challenges of their profession – from stories that showcase nurse heroes like Qun Xia and Liangju Jiao, to hand care tips through to simple yoga and meditation practices and extending support to the nurses’ families.

“All of our nurses are extraordinary people doing extraordinary work in these extraordinary times,” said Harry de Wit, President and CEO of Fresenius Medical Care, Asia Pacific. “International Nurses Day is always an important day for us. This year, it has become a momentous occasion where we are able to both celebrate and support our nurses and their families for the ways in which they have gone above and beyond to care for our patients in such challenging times – a time where they are truly nursing the world back to health – as the official theme of this year’s International Nurses Day states.”

More ‘Stories of Strength’ of Fresenius Kidney Care healthcare heroes can be found on our LinkedIn:

Qun Xiao’s story: https://www.linkedin.com/feed/update/urn:li:activity:6658922704344887297

Liangju Jiao’s story: https://www.linkedin.com/feed/update/urn:li:activity:6656737662566785024

Mingxia Xu’s story: https://www.linkedin.com/feed/update/urn:li:activity:6653909576041234432

Dr. Angel Zhang and Rose Xu’s story: https://www.linkedin.com/feed/update/urn:li:activity:6661093178508226560

For further information, please contact: Dr Alexandra Villar: Alexandra.Villar@fmc-asia.com


Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,002 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 348,703 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

For more information visit the company’s website at www.freseniusmedicalcare.asia


This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

© Business Wire 2020

share with twitter share with LinkedIn share with facebook
10/23FRESENIUS SE : Receives a Buy rating from Goldman Sachs
10/23FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
10/22FRESENIUS SE : Credit Suisse reiterates its Neutral rating
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse remains Neutral
10/21FRESENIUS SE : Berenberg reiterates its Buy rating
10/21Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t..
10/21FRESENIUS SE : Barclays reiterates its Buy rating
10/21FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Barclays
10/20FRESENIUS MEDICAL CARE : gets FDA approval for Biofine® PD solution bags
More news
Financials (USD)
Sales 2020 21 508 M - -
Net income 2020 1 548 M - -
Net Debt 2020 14 308 M - -
P/E ratio 2020 15,4x
Yield 2020 1,74%
Capitalization 23 836 M 23 792 M -
EV / Sales 2020 1,77x
EV / Sales 2021 1,66x
Nbr of Employees 124 736
Free-Float 65,1%
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 99,78 $
Last Close Price 81,40 $
Spread / Highest target 41,0%
Spread / Average Target 22,6%
Spread / Lowest Target -1,84%
EPS Revisions
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer